Anti-Sarilumab Neutralizing Antibody ELISA kit

Catalog No.

KAC36952

Detection method

Colorimetric

Sample type

Plasma, Serum

Assay type

Quantitative

Range

15.625-1,000 ng/ml

Precision

CV<20%

Recovery

80-120%

Shipping

2-8 ℃

Stability and Storage

The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.

Alternative Names

REGN88,SAR153191, CAS: 1189541-98-7

Care for adults with COVID-19: living guidelines from the National COVID-19 Clinical Evidence Taskforce., PMID:36150213

Immune-related adverse events of biological immunotherapies used in COVID-19., PMID:36091800

A guide to immunotherapy for COVID-19., PMID:35064248

Application of systems biology-based in silico tools to optimize treatment strategy identification in Still's disease., PMID:33892792

Anti-IL6 Autoantibodies in an Infant With CRP-Less Septic Shock., PMID:31781117

Immunogenicity of Sarilumab Monotherapy in Patients with Rheumatoid Arthritis Who Were Inadequate Responders or Intolerant to Disease-Modifying Antirheumatic Drugs., PMID:31090044

Document Download

Anti-Sarilumab Neutralizing Antibody ELISA kit.pdf